Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a month ago

Possible Interaction: Adrenergic Beta-Antagonists and Glucose

Research Papers that Mention the Interaction

For glucose control , being treated with beta-blockers and/or diuretics was a negative factor.
Blood pressure  •  2009  |  View Paper
The commonly used antihypertensive drugs, thiazides and betablockers , both induce impairments in both glucose and lipid metabolism and the thiazides are known to cause an elevation of serum urate.
Upsala journal of medical sciences  •  1991  |  View Paper
In addition, beta-blocking agents influence the secretion of many hormones, which regulate glucose.
Annals of clinical research  •  1982  |  View Paper
The ER stress, SO production, and cell death induced by 27.5 mM dextrose were inhibited by all 3 beta blockers tested.
American journal of therapeutics  •  2016  |  View Paper
On multivariate … analysis beta-blockers use before stroke was … with reduced risk of glucose level on admission ≥7.8 mmol/L (OR: 0.22, 95%CI: 0.07-0.74) and fasting glucose on day 1 ≥ 7.0 mmol/L (OR: 0.21, 95%CI: 0.05-0.91).
Plasma glucose level on admission (6.0 ± 1.4 vs 6.6 ± 1.9 mmol/L, P = 0.01) and fasting … ± 1.1 vs 5.7 ± 1.1 mmol/L, P = 0.02) were significantly lower in patients treated with beta-blockers before stroke than in … such a treatment.
Atherosclerosis  •  2012  |  View Paper
The weaknesses identified include the adverse effect of older beta-blockers on glucose control and stroke protection, especially in older persons.
Clinical cardiology  •  2008  |  View Paper
CONCLUSION Older beta-blockers have been shown to have detrimental effects on glucose or lipid parameters.
CONCLUSION Older beta-blockers have been shown to have detrimental effects on glucose or lipid parameters.
Journal of managed care pharmacy : JMCP  •  2007  |  View Paper
Thus, vasodilating beta blockers , by being neutral on glycemic and metabolic factors, are associated with less use of additional medication for lipid or glucose control and may provide a potentially greater cardiovascular risk reduction by virtue of these effects.
Journal of clinical hypertension  •  2006  |  View Paper
It is well known that diuretics and beta blockers can increase plasma glucose and, in available hypertension trials, diuretics and beta blockers caused a higher incidence of NOD than new antihypertensive drugs.
Journal of clinical hypertension  •  2006  |  View Paper
However, older antihypertensive agents such as thiazide diuretics and beta-blockers have potentially adverse effects on glucose and lipid metabolism and may even the exacerbate the metabolic syndrome and increase risk of type 2 diabetes.
The American journal of medicine  •  2006  |  View Paper
Show More